Docking studies reveal zerumbone targets β-catenin of the Wnt-β-catenin pathway in breast cancer

Abstract

Breast cancer is the second most common cancer among women worldwide. The Wnt–β-catenin pathway appears to be deregulated in most cancer cells including breast cancer. The role of zerumbone, the active sesquiterpene from Zingiber zerumbet Roscoe, on the Wnt–β-catenin pathway is relatively unknown, especially detailed molecular studies have yet to be published. Using the Chemistry at HARvard Macromolecular Mechanics (CHARMm) force field-based docking protocol, CDOCKER, the molecular interactions between zerumbone and key proteins of the Wnt–β-catenin pathway were evaluated in this study. The results suggest that zerumbone has a strong affinity for free β-catenin in the cytoplasm, as well as the β-catenin–transcription factor 4 complex in the nucleus. The overall hydrophobic nature of zerumbone allowed its interaction with other hydrophobic residues, such as Trp383, while its active α,β-unsaturated carbonyl facilitated its interaction with positively charged residues, such as Lys345, Arg386 and Asn415 in the β-catenin binding pocket. However, the Wnt protein and its frizzled receptor showed no attraction to zerumbone.

Keywords

• zerumbone
• Wnt-β-catenin pathway
• frizzled (Fzd) protein
• β-catenin-transcription factor 4 complex
• molecular docking